World's Best Scientists 2026 revealed!
Sophie Leboulleux

Sophie Leboulleux

D-Index & Metrics

Medicine

D-Index
89
Citations
27819
World Ranking
12733
National Ranking
174

Sophie Leboulleux publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Sophie Leboulleux sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 406 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Sophie Leboulleux D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Sophie Leboulleux sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Sophie Leboulleux is affiliated with the University of Geneva in Switzerland. Their research primarily focuses on the field of Medicine, with significant contributions in subfields such as Endocrinology, Diabetes and Metabolism, Surgery, Radiology, Nuclear Medicine and Imaging, Oncology, and Genetics.

The main topics of their work include:

  • Thyroid Cancer Diagnosis and Treatment
  • Thyroid and Parathyroid Surgery
  • Adrenal and Paraganglionic Tumors
  • Radiomics and Machine Learning in Medical Imaging
  • Radiopharmaceutical Chemistry and Applications
  • Pituitary Gland Disorders and Treatments
  • Neuroendocrine Tumor Research Advances

Leboulleux has published extensively, with frequent contributions to several scientific journals. The most common publication venues are:

  • Annales d Endocrinologie
  • Annals of Oncology
  • Endocrine
  • Endocrine Abstracts
  • The Lancet Diabetes & Endocrinology

Among recent notable publications authored or co-authored by Leboulleux are:

  • "Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer," 2022, New England Journal of Medicine
  • "ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer," 2022, Annals of Oncology
  • "Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study," 2021, The Lancet Diabetes & Endocrinology
  • "Current practice in patients with differentiated thyroid cancer," 2020, Nature Reviews Endocrinology
  • "Efficacy of Selpercatinib in RET-Altered Thyroid Cancers," 2020, New England Journal of Medicine

Leboulleux has collaborated frequently with several researchers in the field. Frequent co-authors include:

  • Livia Lamartina
  • Julien Hadoux
  • Éric Baudin
  • Yann Godbert
  • Martin Schlumberger

Best Publications

  • Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma : benefits and limits of radioiodine therapy

    C. Durante;N. Haddy;E. Baudin;S. Leboulleux

  • Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

    S Filetti;C Durante;D Hartl;D Hartl;S Leboulleux;S Leboulleux

  • Combination Chemotherapy in Advanced Adrenocortical Carcinoma

    Martin Fassnacht;Massimo Terzolo;Bruno Allolio;Eric Baudin

  • Prognostic Factors for Persistent or Recurrent Disease of Papillary Thyroid Carcinoma with Neck Lymph Node Metastases and/or Tumor Extension beyond the Thyroid Capsule at Initial Diagnosis

    Sophie Leboulleux;Carole Rubino;Eric Baudin;Bernard Caillou

  • Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer

    Martin Schlumberger;Bogdan Catargi;Isabelle Borget;Désirée Deandreis

  • Ultrasound Criteria of Malignancy for Cervical Lymph Nodes in Patients Followed Up for Differentiated Thyroid Cancer

    Sophie Leboulleux;Elizabeth Girard;Mathieu Rose;Jean Paul Travagli

  • Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.

    F Pacini;F Pacini;Pw Ladenson;M Schlumberger;A Driedger

  • Efficacy of Selpercatinib in RET-Altered Thyroid Cancers

    Lori J Wirth;Eric Sherman;Bruce Robinson;Benjamin Solomon

  • Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.

    Claudia Scollo;Eric Baudin;Jean-Paul Travagli;Bernard Caillou

  • Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial

    Sophie Leboulleux;Lars Bastholt;Thomas Michael Krause;Christelle de la Fouchardiere

  • The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.

    Nelly Burnichon;Nelly Burnichon;Vincent Rohmer;Laurence Amar;Laurence Amar;Philippe Herman

  • Medullary thyroid carcinoma.

    Sophie Leboulleux;Eric Baudin;Jean-Paul Travagli;Martin Schlumberger

  • Definition and management of radioactive iodine-refractory differentiated thyroid cancer

    Martin Schlumberger;Marcia Brose;Rosella Elisei;Sophie Leboulleux

  • Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients.

    E. Baudin;C. Do Cao;A. F. Cailleux;S. Leboulleux

  • Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment.

    Stéphane Bonnet;Dana Hartl;Sophie Leboulleux;Eric Baudin

  • Are G3 ENETS neuroendocrine neoplasms heterogeneous

    Fritz-Line Vélayoudom-Céphise;Pierre Duvillard;Lydia Foucan;Julien Hadoux

  • Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times.

    Anne Laure Giraudet;Abir Al Ghulzan;Anne Aupérin;Sophie Leboulleux

  • Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.

    Anne Laure Giraudet;Daniel Vanel;Sophie Leboulleux;Anne Aupérin

  • Prognostic parameters of metastatic adrenocortical carcinoma.

    Guillaume Assié;Guillemette Antoni;Frédérique Tissier;Bernard Caillou

  • Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy.

    Renaud De Crevoisier;Eric Baudin;Anne Bachelot;Sophie Leboulleux

Frequent Co-Authors

Eric Baudin
Eric Baudin Institut Gustave Roussy
Martin Schlumberger
Martin Schlumberger University of Paris-Saclay
Michel Ducreux
Michel Ducreux Institut Gustave Roussy
Jacques Young
Jacques Young University of Paris-Saclay
Jérôme Bertherat
Jérôme Bertherat Université Paris Cité
Pierre Duvillard
Pierre Duvillard Institut Gustave Roussy
Dominique Elias
Dominique Elias Institut Gustave Roussy
Thierry de Baere
Thierry de Baere Institut Gustave Roussy
Martin Fassnacht
Martin Fassnacht University of Würzburg
Anne-Paule Gimenez-Roqueplo
Anne-Paule Gimenez-Roqueplo Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine isn’t limited to becoming a physician. The healthcare field is vast, and many students are now looking towards specialized online degrees to broaden their career options or advance within the industry. For example, pursuing one of the most affordable online mha programs can lead to leadership roles in hospital administration or policy development.

Fast-tracked programs like a 1 year dnp program online help experienced nurses achieve top clinical qualifications in a flexible format, making career advancement more accessible. Meanwhile, an online pharmacist degree can prepare you for licensed pharmacist roles without the commitment to traditional on-campus learning.

Professionals looking for a technical career can also consider rhit programs online. These programs focus on health information management, perfect for those interested in data analysis, patient records, and compliance. Online learning makes these pathways flexible and affordable, ideal for working professionals or students balancing other commitments.

Best Scientists Citing Sophie Leboulleux

Trending Scientists

Recently Published Articles